# Caption Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caption-health

- Industry: Software
- Headquarters: San Mateo, US
- Website: www.captionhealth.com
- Total disclosed funding: $61M
- Latest round: Series B (Mar 25, 2020)
- Investors on record: 11

## About

Caption Health, Inc. is a US-based healthcare technology firm specializing in AI-driven ultrasound solutions aimed at enhancing diagnostic imaging capabilities for healthcare providers.Founded in 2013 in San Mateo, California, Caption Health, Inc. develops AI technologies for ultrasound imaging. The company was established by Kilian Koepsell and has undergone significant growth, culminating in a recent acquisition by GE Healthcare in February 2023. Caption Health has successfully raised a total of USD 52.77 mn through various funding rounds, with its latest round being a Grant of USD 4.95 mn from the Bill & Melinda Gates Foundation.Caption Health's core offerings include advanced ultrasound systems integrated with AI features like Caption Guidance, AutoCapture, and AutoMeasure. These tools facilitate high-quality cardiac imaging and improve workflow for healthcare professionals across cardiology, women's health, and general imaging sectors. Their products are marketed globally, serving a diverse clientele in regions including the United States, Europe, and Asia, particularly where advanced healthcare technology is increasingly adopted.Caption Health generates revenue through direct sales of its AI-enhanced ultrasound systems and related services to healthcare institutions. Their B2B model allows them to partner with healthcare providers, integrating their technologies into clinical practice. The offerings include systems such as the Vivid and LOGIQ ultrasound devices, often bundled with installation, training, and ongoing support, with pricing tailored to meet the specific needs of their clients.Following the acquisition by GE Healthcare, Caption Health is poised to leverage this partnership to enhance its product offerings and expand its global reach. The recent funding will support the development of new ultrasound technologies, with plans to introduce an updated product line in the coming months. The company targets expansion into new markets, particularly in Europe and Asia, by the end of 2024, capitalizing on the growing demand for advanced imaging solutions in these regions.

## Funding rounds

- Series B, Mar 25, 2020, $53M — Atlantic Bridge, Khosla Ventures, Edwards Lifesciences Corporation, DCVC, LDV Management, NYP Ventures, Gopher US Partners
- Series A, Dec 14, 2017, $5.5M — Khosla Ventures, DCVC, Greenbox Venture Partners, Minneapolis Heart Institute Ventures
- Seed, Jan 28, 2016, $2.5M — Khosla Ventures, National Science Foundation, 11.2 Capital

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed, Series A, Series B
- National Science Foundation — Seed
- 11.2 Capital (https://capitalatlas.ai/funds/11-2-capital) — Seed
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A, Series B
- Greenbox Venture Partners (https://capitalatlas.ai/funds/greenbox-venture-partners) — Series A
- Minneapolis Heart Institute Ventures — Series A
- Atlantic Bridge (https://capitalatlas.ai/funds/atlantic-bridge) — Series B
- Edwards Lifesciences Corporation — Series B
- LDV Management (https://capitalatlas.ai/funds/ldv-management) — Series B
- NYP Ventures (https://capitalatlas.ai/funds/nyp-ventures) — Series B
- Gopher US Partners — Series B